信隆健康(002105.SZ):2019年度審計機構擬由瑞華所變更為中匯所
格隆匯10月22日丨信隆健康(002105.SZ)公佈,公司第六屆董事會第二次會議審議通過了《關於變更會計師事務所的議案》,公司擬變更公司2019年度審計機構為中匯會計師事務所(特殊普通合夥),該議案尚需提交公司股東大會審議。
經公司2018年度股東大會審議通過,公司原聘請了瑞華會計師事務所(特殊普通合夥)(“瑞華所”)為公司2019年度審計機構,為公司提供審計服務。現根據公司戰略發展及未來審計的需要,同時鑑於瑞華事務所已連續多年為公司提供審計服務,為保證公司審計的獨立性,經公司第六屆董事會第二次會議審議通過,公司擬變更會計師事務所,擬聘請中匯會計師事務所(特殊普通合夥)(“中匯所”)為公司2019年度審計機構,聘期一年。公司董事會對瑞華所多年來提供的專業、嚴謹、負責的審計服務表示衷心的感謝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.